MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prevalence of Parkinson’s disease and parkinsonism in Kyrgyzstan

C. Shambetova (Bishkek, Kyrgyzstan)

Meeting: 2019 International Congress

Abstract Number: 1070

Keywords: Levodopa(L-dopa), Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Aim of the study is to determine frequency and overall picture of disease characteristics, evaluation and treatment of patients with Parkinson’s disease (PD) and parkinsonian syndromes (PS) at third-level university based hospital over the period of 2 years in Kyrgyzstan, by reviewing medical records.

Background: The information on prevalence and frequency of PD and PS in Central Asia is very limited.

Method: The staff of two neurology departments are eight neurologists with second, first and highest local category of specialization and no movement disorders (MD) training. Medical records are paper based general forms, as there is still no electronic data base recording system. Neurologist with MD training reviewed medical records of patients with PD and PS of January 2016-December 2017 period. Age, gender, age at onset, clinical features, diagnostic evaluation, and treatment, were extracted and filled in a standardized form, created for the study.

Results: 127 (55.8%) of MD patients were referred from primary clinics over the country with initial diagnosis of PD in 52 (40.9%) cases and PS in 75 (59.1%). There were 62 males and 65 females with mean age of 60.8±10.9 years (range, 34-91). Mean age at onset was 55.9 years (29-86) and median duration of disease by the visit was 4.71 years (several months to 21 years). Only in 55 (43.3%) cases PD was concluded as final diagnosis. 72 patients (56.7%) were diagnosed with PS: vascular parkinsonism (76.4%), and not identified parkinsonism (23.6%). There was no case with diagnosed atypical parkinsonism (AT), yet at least 29 patients had to be considered for AT due to disease characteristics and history. Brain MRI obtained in 55/127 (43.3%). 71 patients (55.9%) were treated with levodopa (in combination bencerazide/carbidopa and entacapone) with typical dose of 250 mg per day, 20 patients (15.7%) were not treated at all. Figure 1 shows information on other medications. There was no documented information on dyskinesia and motor fluctuations. Only in 27.6% Hoehn Yahr scale was applied. Records of parkinsonian features examination were insufficient, non-motor symptoms were not taken into consideration and treated.

Conclusion: Low level of diagnosed PD and high level of not identified PS, along with other data, is a clear indication of high rate of inadequate diagnosis and treatment of MD patients, proving necessity to continue the work on improvement of knowledge and skills of local neurologists.

MDC 2019

To cite this abstract in AMA style:

C. Shambetova. Prevalence of Parkinson’s disease and parkinsonism in Kyrgyzstan [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/prevalence-of-parkinsons-disease-and-parkinsonism-in-kyrgyzstan/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prevalence-of-parkinsons-disease-and-parkinsonism-in-kyrgyzstan/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley